Gottlieb RL, Nirula A, Chen P, et al. Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial. JAMA. 2021;325(7):632–644. doi: 10.1001/jama.2021.0202.

Kim YJ, Jang US, Soh SM, Lee JY, Lee HR. The impact on infectivity and neutralization efficiency of SARS-CoV-2 lineage B.1.351 Pseudovirus. Viruses. 2021;13(4):633. doi: 10.3390/v13040633.

Anti-SARS-CoV-2 Monoclonal Antibodies. National Institutes of Health, US Department of Health and Human Services; www.covid19treatmentguidelines.nih.gov/anti-sars-cov-2-antibody-products/anti-sars-cov-2-monoclonal-antibodies.

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19. US Food and Drug Administration; https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19.

Pharmacologic Interventions. National Institutes of Health, US Department of Health and Human Services; www.covid19treatmentguidelines.nih.gov/critical-care/pharmacologic-interventions/